BUPE2021.COMBUPE2021.COM
  • Home
  • Presentations
  • Posters
  • Info
    • ——————————
      • Call For Presentations, Posters, etc
      • CME Information
        • Conference Chairs
      • Presentations – Preview
    • ——————————
      • Press & Media
        • Contact Us
        • Speakers
    • ——————————
      • Conference Information
      • Terms and conditions
      • Tickets
    • ——————————
      • Educational Support
      • Satellite Symposia
      • Sponsorship & Exhibits
  • Register Now to Watch
  • Login
  • Get Started Now!
  • Home
  • Presentations
  • Posters
  • Info
    • ——————————
      • Call For Presentations, Posters, etc
      • CME Information
        • Conference Chairs
      • Presentations – Preview
    • ——————————
      • Press & Media
        • Contact Us
        • Speakers
    • ——————————
      • Conference Information
      • Terms and conditions
      • Tickets
    • ——————————
      • Educational Support
      • Satellite Symposia
      • Sponsorship & Exhibits
  • Register Now to Watch
  • Login
  • Get Started Now!
Call For Papers

Call For Papers

Call for Presentations, Symposia and Posters

Updated October 13, 2021

Please click here to download the BUPE2021 Abstract Form.

Join us for BUPE2021 November 12, 2021

“Buprenorphine: Clinical and Public Policy Implications”

This virtual conference will compliment Journal of Opioid Management’s Special Issue on Buprenorphine.

    Journal of Opioid Management (JOM) is pleased to present a special conference titled, Buprenorphine: Clinical and Public Policy Implications (BUPE2021) November 12, 2021, focused on all aspects of the use of buprenorphine in medicine. Combined with our soon to be released special issue on this topic, our goal is to broaden the knowledge base on buprenorphine, its potential in the healing pharmacopeia and as a pharmacological tool for pain management and/or addiction.

This unique one day online forum will be comprised of renowned specialists presenting the latest advances in basic science, neurology, clinical application, pharmacology, pharmacogenetics, public health, opioid addiction, ethics, legal, regulatory and compliance. The program is designed to enlighten healthcare providers with new data, essential information, and best practices every medical professional needs to know when caring for patients using buprenorphine.

We request proposals from all areas of research, treatment, ethics, opioid abuse and addiction. Proposals from individuals and panels will be considered. Multidisciplinary panels are encouraged to include perspectives from physicians, nurses, psychologists, basic scientists, pharmacists, etc. Moderators should seek participation from a varied group of faculty with a maximum of four participants per proposal.

The following partial list of topics are suggested for submission:

· Clinical application of buprenorphine in pain management
· Where does buprenorphine fit on the ladder of analgesics?
· Rescheduling of buprenorphine to replace NSAIDS
· How does one rotate onto buprenorphine from other potent opioids?
· How does one rotate from buprenorphine to other opioids?
· The nuances of buprenorphine PK/PD and its clinical relevance
· Clinical utility of buprenorphine relative to other opioids, safer or not?
· Clinical application of buprenorphine in addiction medicine
· Perioperative management of patients on long-term buprenorphine
· Breakthrough pain management on buprenorphine
· Populations that would likely benefit from using buprenorphine up front
· Buprenorphine in complex persistent opioid dependence  
· Buprenorphine in opioid use disorders
· How safe is buprenorphine in organ failure?
· Comparison of buprenorphine delivery technologies
· PK/PD of various formulations and delivery platforms
· Suboxone as an analgesic off-label
· Are benzodiazepines OK for a patients on long-term buprenorphine?
· Can patients overdose on buprenorphine?
· The role of buprenorphine in addressing the opioid crisis
· Economic considerations in prescribing buprenorphine
· Integration of buprenorphine into practice protocols
· Impact of buprenorphine on crime and legal issues
· Legislation impacting buprenorphine adoption
· Inequalities in pain experience and pain management
· Ethical issues in the use of buprenorphine
· Interpretation of urine drug screen results
· How to manage patients on cannabis and buprenorphine?
· How to avoid legal problems in today’s environment?
· Exploring the role buprenorphine plays in the US drug crisis
· NIH Interagency Pain Management recommendations

Proposals for previously presented or published work may not be submitted without modification and must be changed or expanded, resulting in a new proposal.

Oral presentation proposals accepted thru September 10, 2021 (Phase 1). Phase 2 – Ongoing through December 15, 2021. ** NOTE: While we have filled the initial program for BUPE2021, we are reviewing and accepting additional presentations that contribute to the understanding on the use of buprenorphine in pain management and other aspects of medicine.  Please use the standard abstract submission form and we will get a decision asap.
Poster abstract submissions accepted thru December 15, 2021.

Please note: The moderator is required to include a complete standard format disclosure form as part of the submission. Moderators should contact the speakers named on the proposal to notify them of their inclusion in the submission, and to remind them to complete their disclosure information for inclusion with the
abstract submission.

A complete proposal submission should include the following:
• Presentation title
• A brief description of the presentation, its need and rationale
for your topic at the BUPE2021 conference.
• Abstract text of up to 200 words, with information about
each presenter’s contribution; a focus statement with succinct description of topics discussed including background, purpose, procedures and conclusions.
• Educational objectives, goals and outcomes.
• Five (5) questions for a post conference test
• Moderator and/or presenter information, including disclosures, bio and picture. Presenter’s bio (250-300 words) should include both educational and professional achievements. Bio provided will be published in speakers guide and used to introduce speakers. Picture must be high-res .jpg file.

Proposal Notification: Applicants will be notified within two (2) weeks of abstract submission. All presenters will receive complimentary conference registration. Other details and terms of participation will be communicated to presenters upon acceptance of their proposal.

Presentation Times: Accepted presentations will be recorded and stored on the conference site. Select presentations may be scheduled for presentation live online at a time determined by the presenters and organizers. During the live online presentation, all presenters may respond to questions. After the presentation has been archived and posted on the Virtual website, only the lead presenter or a designate will answer email-based questions. Symposium sessions are 30-60 minutes in length. Panel presentations involving multiple presenters will be given additional time.

Presentation Materials: PowerPoint slides are required and are due within 21 days of acceptance of presentation for content review. MP4 video files can be recorded as soon as content review is complete. PDF handouts of slides will be posted with the video. The session moderator will be expected to assist the organizers in the collection and organization of all presentation slides and handout materials.

Poster Details: Poster submissions may have been previously
presented. Video posters must be original unreleased video and should be no more than 15 minutes in length. Poster presenters
are required to register for the conference.

Submission Details: To submit all proposals:
-> Please click here to download the BUPE2021 Abstract Form.

-> Please Click here for standard format disclosure form to be submitted with abstract.

Email your form to jom@pnpco.com. For assistance contact us at 781-899-2702, ext 108 or 114 from 9 am – 4 pm EST.

Important Dates:
• Oral presentation submissions through September 10, 2021. (Phase 1). Phase 2 – Ongoing through December 15, 2021. ** NOTE: While we have filled the initial program for BUPE2021, we are reviewing and accepting additional presentations that contribute to the understanding on the use of buprenorphine in pain management and other aspects of medicine.  Please use the standard abstract submission form and we will get a decision asap.
• Presentation and symposia decision 2 weeks of abstract acceptance.
• Poster abstract submission deadline extended through December 15, 2021.
• Presentation slides due for CME content review within 21 days
of decision.

 

BUPE2021 is presented by the Journal of Opioid Management. We are dedicated to presenting the latest research and practice for managing patients on opioid therapies.

INFORMATION
  • Terms and conditions
  • Privacy Statement
Looking for more? Sign up today!

    Contact Us
    jom@pnpco.com
    Copyright 2022 Weston Medical Publishing, LLC - All Rights Reserved
    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    Privacy Statement


    Privacy and User Data Policy

    GDPR Update:

    The data collected from registered and non-registered users of this journal falls within the scope of the standard functioning of peer-reviewed journals. It includes information that makes communication possible for the editorial process; it is used to informs readers about the authorship and editing of content; it enables collecting aggregated data on readership behaviors, as well as tracking geopolitical and social elements of scholarly communication.

    This journal’s editorial team uses this data to guide its work in publishing and improving this journal. Data that will assist in developing this publishing platform may be shared with its developer Public Knowledge Project in an anonymized and aggregated form, with appropriate exceptions such as article metrics. The data will not be sold by this journal or PKP nor will it be used for purposes other than those stated here. The authors published in this journal are responsible for the human subject data that figures in the research reported here.

    Those involved in editing this journal seek to be compliant with industry standards for data privacy, including the European Union’s General Data Protection Regulation (GDPR) provision for “data subject rights” that include (a) breach notification; (b) right of access; (c) the right to be forgotten; (d) data portability; and (e) privacy by design. The GDPR also allows for the recognition of “the public interest in the availability of the data,” which has a particular saliency for those involved in maintaining, with the greatest integrity possible, the public record of scholarly publishing.

    Requests per item (a) through (e) above should be sent to the journal's mailbox, jom(at)pnpco.com

    The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

    What Data does this Website Process?

    The system, based the PKP Open Journal System applications, process personal data as a fundamental part of their operations. Most data is only provided by consent, ie. through manual user registration, though some visitation data (eg. cookies, usage logs) may also be recorded.

    User Registration Data

    When a visitor creates a user account in a PKP application, the following personal information is processed and stored (with some minor variation between OMP and OJS, and from version to version):

    ●   Salutation

    ●   First name*

    ●   Middle name

    ●   Last name*

    ●   Suffix

    ●   Username

    ●   Gender

    ●   Password (encrypted)

    ●   Email address*

    ●   ORCiD ID

    ●   Website

    ●   Mailing Address

    ●   Country

    ●   Phone

    ●   Fax

    ●   Affiliation

    ●   Biography

    ●   Registration date

    ●   Last login date

    ●   Locales

    ●   Reviewing interests

    ●   Role registrations (author, reader, and/or reviewer)

    Only the username, first name, last name, email and password fields are required.

    Storage

    This information is stored in the application database. Only the user password

    is encrypted.

    Availability and Access

    This information is available to the user via their User Profile (and, with the exception of the username and dates, can be edited). System administrators, journal managers, and editors can also access and edit this data (except the username and dates) via the application back end. The data can be downloaded by journal managers in XML format. The data is not otherwise publicly available.

    Erasure

    This data can be erased by the journal manager using the Merge Users tool, without affecting any editorial records. The erasure is subject to the considerations raised in the section “Scholarly Publishing, Data Privacy, and the Public Interest”, above.

    Contributor Metadata Information

    When a manuscript is submitted to a PKP application, contributor information is included. Contributors can be authors, translators, volume editors, and so on. This information is stored as submission metadata and is provided as part of any published manuscript record. The following contributor information is collected:

    ●   Salutation

    ●   First name*

    ●   Middle name

    ●   Last name*

    ●   Email address*

    ●   Suffix

    ●   ORCiD ID

    ●   Website

    ●   Country*

    ●   Affiliation

    ●   Biography

    Only the first name, last name, email address and country fields are required.

    Storage

    This information is stored in the application database.

    Data Transfer

    We do not sell or transfer to third parties user information from this system.

    General Visitor Information

    PKP applications also collect general visitor usage data, including:

    ● Cookie information, to manage session history. Cookies are required to maintain a login session in PKP applications.

    ● Optionally, detailed usage log data, including: IP address; pages visited; date visited; and browser information, in application log files, as part of the Usage Statistics plugin. An anonymization option is available to privatize this information.

    ● Optionally, country, region and city information, in the metrics database. This data collection requires additional setup and is not enabled by default.

    Other data may be tracked, either on the server or via third parties:

    ● Script loads from CDN servers;

    ● IP address information (including date, browser, etc.) in web server logs (separate from application log files as part of the Usage Statistics plugin).

    Detailed instructions in limiting the amount of data you collect, and providing consent for the data you collect, can be found below.

    Storage

    ● Cookies: A cookie (usually titled “OJSSID” or “OMPSID”) is created when first visiting a PKP application and is stored on the visitor’s computer. It is only used to store a session ID, and to facilitate logins. (If the visitor blocks cookies, OJS will still work properly, though they will not be able to log in.)

    ● Usage Statistics log files: As part of the usage statistics framework and plugin, OJS may store detailed application log files in the submission files directory (configured as the files_dir parameter in the OJS config.inc.php file), in a “usageStats” directory.

    ● Geographical data: Filtered usage data, including possibly geographic data, is also stored in the OJS database, in a “metrics” table.

    Availability and Access

    ● Cookies: These are available via the visitor’s browser settings.

    ● Usage Statistics log files: Only individuals with server file access can access application log files.

    ● Geographical data: Journal Managers can access filtered usage data by using the OJS usage report plugins.

    Erasure

    ● Cookies: These can be deleted via the visitor browser.

    ● Usage Statistics log files: These can be erased by system administrators with file access.

    ● Geographical data: This can only be erased by deleting records from the database directly, which also typically requires system administrator access.

    Portions of this privacy statement are copyright by Simon Fraiser University Licensed wth CC4.0-BY.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT